Kathleen M. Boozang   

Dean Kathleen M. Boozang (2019)

Dean & Professor of Law

  • Degrees:

  • LL.M., Yale Law School |
  • J.D., Washington University School of Law |
  • B.S., Boston College
  • Contact:

  • [email protected]
  • Tel:  973-642-8501
  • SSRN Site link
  • Curriculum Vitae
  • Courses:

  • Pharmaceutical and Medical Device, Marketing & Compliance, Health Law, Death and Dying

Kathleen Boozang has been Dean of Seton Hall Law since July 2015. Seton Hall Law has always put students first, and that ethos continues under Dean Boozang. Her deanship is best captured by the Law School’s mantra – One Student at a Time. This represents Seton Hall Law’s commitment to partner with its students one at a time to discover their passion and to forge the pathway to fulfilling their aspirations. One Student at a Time also represents Seton Hall Law’s commitment to seeing every student possible through law school to the bar, irrespective of the obstacles that may arise.

Dean Boozang came to Seton Hall in 1990 as the founder of the Law School’s now top-ranked Center for Health & Pharmaceutical Law. Prior to becoming Dean, she also established the Law School’s graduate degrees, Division of Online Learning and global life sciences compliance training programs. Seton Hall Law’s graduate degree program for non-lawyers in compliance, privacy, risk management and cybersecurity is one of the largest such programs in the country, and continues to grow.

Dean Boozang’s first two initiatives upon becoming dean were to create the position of Assistant Dean of Equity, Diversity and Engagement and to convert the Law School’s part-time evening program to an innovative Weekend hybrid program. Seton Hall Law aspires to equality of outcomes for every student and employee, and this philosophy informs Dean Boozang’s leadership. The Weekend program is an example of expanding access to the legal profession for mid-career professionals; the inaugural class of 2021 achieved a first-time bar pass rate of 87%. Currently, the Law School is expanding its curricular, co-curricular and professional programming in Sports, Gaming, Hospitality and Entertainment. And, of course, much of Dean Boozang’s tenure has focused on successful navigation of the Law School through COVID – Seton Hall Law classes remained in-person through all but two months in Spring 2020.

Dean Boozang has taught a variety of health law courses in person and online including health law, health care fraud and corruption, tax-exempt organizations, and death and dying. In her scholarship, Dean Boozang has dedicated much of her career to nonprofit governance issues with a special focus on religiously sponsored hospitals. In the last several years, however, she has expanded her research and teaching to explore the legal and policy issues related to corporate compliance, with a particular focus on the global life sciences industry. Dean Boozang has also taught Torts, Contracts and Professional Responsibility in the One L curriculum.

Dean Boozang is a Fellow of The Hastings Center, an independent nonprofit bioethics research institute, as well as a Fellow of the American Bar Foundation, an honorary organization of legal practitioners. She is also a member of the American Law Institute and participated on the consultant groups for the Principles of Nonprofit Law and Corporate Compliance. She has served on the Editorial Board of the Journal of Health and Life Sciences Law and is a past editor-in-chief of the Journal of Law, Medicine & Ethics. She is past president of the American Society of Law, Medicine & Ethics (ASLME) and also previously sat on the Advisory Board of the Journal of Health Law. Dean Boozang served for many years on the Board of Directors of the American Health Lawyers Association (AHLA) and remains involved in many AHLA projects.

Dean Boozang has served on multiple boards, including the Board of Trustees of the St. Joseph Healthcare System in New Jersey. In 2013, the ASLME conferred upon Dean Boozang the Jay Healy Health Law Teacher Award. She was named the Seton Hall University Woman of the Year in 2006 and the Washington University Law School’s Young Alum of the Year in 2004. She graduated from Washington University School of Law in St. Louis, Missouri, where she was inducted into the Order of the Coif and served as the managing editor of Law Quarterly (now the Law Review). She received her LL.M. from Yale Law School in 1990.



Responsible Corporate Officer Doctrine: When is Falling Down on the Job a Crime?, 6 J. Health L & Pol'y 77 (2012)

"Monitoring" Corporate Corruption: DOJ's Use of Deferred Prosecution Agreements in Health Care, 35 Am. J.L. Med. 89 (Spring 2009) (with Simone Handler-Hutchinson)

A Civil Law Analysis: The Place of Religion in Treatment Termination Decision-Making, 15 Temp. Civ. Rts. L. Rev. 345 (2007)

Does Director Independence Improve Nonprofit Governance?, 75 Tenn. L. Rev. 83 (2007)

Mission, Margin and Trust in the Nonprofit Healthcare Enterprise, 5 Yale J. Health Pol’y, L. and Ethics 1 (2005) (T.L. Greaney)

Therapeutic Placebos: Making the Case for Patient Deception, 54 Fla. L. Rev. 687 (2002)

CAM for Kids, 1 Houston J. Health L. & Pol'y 109 (2001)

Is the Alternative Medicine? Managed Care Apparently Thinks So, 32 Conn. L. Rev. 567 (2000)

An Intimate Passing: Restoring the Role of Family and Religion in Dying, 58 U. Pitt. L. Rev. 549 (1997)

The Survival of Religious Hospitals in a World of Reformed Health Care, 31 Houston L. Rev. 1429 (1995)

Death Wish: Resuscitating Self-Determination for the Critically Ill, 35 Ariz. L. Rev. 23-85 (1993)


Entry: Organizational Ethics in the Healthcare Sector, in Bioethics, Bruce Jennings ed., 4th Edition (2014)

Legal and Ethical Issues in Complemantary and Alternative Medicine, in Complementary and Alternative Medicine: An Evidence Based Approach, Spencer & Jacobs (John Spencer & Joe Jacobs) (2003)

Problems and Conflicts Between Law and Morality in a Free Society, in Is There a Right to Life at the End of Life?, (James E. Wood & Derek Davis) (1994)


The New Relator: In-House Counsel and Compliance Officers, 6 J. Health & Life Sciences L. 16 (2012)

Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J L Med Ethics (2012) (with Carl Coleman and Kate Greenwood)

Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)

An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)

A New Pathway to Market for Biosimilars, 4 J. H & Life Sciences L. 121 (2010) (with Judith Toffentti)

Board Independence and Transparency: Searching for the Key to Good Governance, 1 J. Health & Life Sci. L. 127 (2009)

Independence and Transparency: Keys to Good Corporate Governance, 1 J. Health & Life Sciences L. 127 (2008)

Independence and Transparency: Keys to Good Corporate Governance, 1 J. Health & Life Sciences L. 127 (2008)

National Policy on CAM: The White House Commission Report, 31 J.L. Med. & Ethics 251 (2003)

Reconciling Health Care Needs and Religious Practices, 5 Gov't L. & Pol'y J. 23 (2003)

Western Medicine Opens the Door to Alternative Medicine, XXIV J. Law & Med. 185 (1998)

Developing a Public Policy Toward the Sectarian Provider: Accommodating Religious Beliefs and Obtaining Patient Access to Care, 24 J. Law, Medicine & Ethics 89 (1996)


The Role and Place of Compliance within Life Sciences: The Imperative of Chief Ethics and Compliance Officer Independence, (2018) (with Timothy Glynn)

The Ban on Off-Label Promotion and the False Claims Act: Analyzing a Decentralized, Public-Private Enforcement Regime, (2015) (collaborator)

Symposium: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?, Center for Religiously Affiliated Nonprofit Corporations & Center for Health & Pharmaceutical Law (2013) (In collaboration with University of St. Thomas)

The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2010) (collaborator)

Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Drug and Device Promotion: Charting A Course for Policy Reform, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)


Case Study: The Abuse of Alternative Medicine?, 33 Hastings Center Rptr. 13-14 (2003)


AHLA Pharmaceutical and Medical Device Compliance Manual, First Ed. (2012) (with Simone Handler-Hutchinson)


The Aspirations and Challenges of Decision Aids, Arizona Syllabus (Spring 2013)


In Defense of the Responsible Corporate Officer Doctrine


Full list of presentations available in Curriculum Vitae

Donald S. Kent Memorial Lecture, A Comparison of the Differences between Legal and Medical Education, New Jersey Medical Society (Fall 2017) (Co-Speaker)

Healthcare Fraud: A Crippling Problem, A Cash Cow, or a Rogue (DOJ) Agenda?, Yale Alumni Assn (Fall 2017)

Getting Students to Talk, ASLME Health Law Teachers Conference, Saint Louis University School of Law (Spring 2015) (Panelist)

The Future of the Compliance Profession, AdvaMed and Eucomed Annual Meeting, Athens, Greece (Spring 2015) (Panelist)

Off-Label Treatment: Use of Cancer Drugs Outside of Conventional Trials and Government Approvals, The Judges and Lawyers Breast Cancer Alert and Women’s Bar Ass’n of the State of New York, New York City Bar Ass’n (Fall 2014) (Speaker)

Annual Flora Barlotta Lecture: End of Life Care, Saint Barnabas Medical Center (Spring 2011)

U.S. Waste Fraud and Abuse Laws, E.U. Corporate Compliance Program (June 2011) (Paris, France)